or Try an Advanced Search...

    Lymphocytic Leukemia Stocks List

    Symbol Grade Name % Change
    LGND B Ligand Pharmaceuticals Incorporated 0.70
    EBS B Emergent Biosolutions, Inc. 3.52
    TEVA B Teva Pharmaceutical Industries 0.55
    BIIB C Biogen Idec Inc. -0.02
    AFMD C Affimed Therapeutics B.V. -0.73
    EGRX C Eagle Pharmaceuticals, Inc. -1.25
    CLLS F Cellectis S.A. 3.48
    GMAB F Genmab A/S -1.11
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
    Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Cancer Biotechnology Drugs Monoclonal Antibodies Monoclonal Antibody Multiple Myeloma Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Biopharmaceutical Blastoma CD19 Cd20

    Related ETFs - A few ETFs which own one or more of the above listed Lymphocytic Leukemia stocks.

    Symbol Grade Name Weight
    ISRA C Market Vectors Israel ETF 9.84
    EIS B iShares MSCI Israel Capped Investable Market Index Fund 9.53
    MNTL B Tema Neuroscience and Mental Health ETF 8.11
    PJP A PowerShares Dynamic Pharmaceuticals 6.86
    FBT B First Trust Amex Biotech Index Fund 6.4
    View all Lymphocytic Leukemia ETFs...
    Compare ETFs
    Compare ISRA to FBT Compare ISRA to MNTL Compare MNTL to FBT

        Lymphocytic Leukemia Stocks Recent News

        Date Stock Title
        Jul 1 TEVA Update: Market Chatter: Teva Pharmaceuticals Faces FTC Probe on Patent Listings
        Jul 1 TEVA Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity
        Jul 1 TEVA Teva focus of FTC investigation over inhaler patents
        Jul 1 GMAB AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
        Jul 1 LGND Lifecore Biomedical Announces Cooperation Agreement with 22NW
        Jul 1 BIIB 10 clinical trials to watch in the second half of 2024
        Jun 28 TEVA New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
        Jun 28 GMAB AbbVie, Genmab blood cancer therapy endorsed in EU
        Jun 28 BIIB Biogen, Eisai launch Alzheimer's drug Leqembi in China
        Jun 28 BIIB Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
        Jun 28 GMAB Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma
        Jun 28 BIIB Eisai and Biogen launch Alzheimer's drug Leqembi in China
        Jun 27 BIIB “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
        Jun 27 GMAB Completion of Share Buy-back Program
        Jun 27 GMAB FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
        Jun 27 LGND Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
        Jun 27 GMAB Genmab, AbbVie win FDA nod for relapsed follicular lymphoma therapy
        Jun 26 GMAB EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
        Jun 26 BIIB FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
        Jun 26 BIIB Pharma M&A: The top high value deals in 2023
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
        Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Cancer Biotechnology Drugs Monoclonal Antibodies Monoclonal Antibody Multiple Myeloma Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Biopharmaceutical Blastoma CD19 Cd20
        Lymphocytic Leukemia

        Lymphocytic leukemia is a type of cancer that affects the white blood cells, or lymphocytes, in the body. It is a type of leukemia, which is a cancer of the blood and bone marrow. In lymphocytic leukemia, the body produces too many abnormal lymphocytes, which can crowd out healthy white blood cells, red blood cells, and platelets. This can lead to anemia, infections, and other serious health problems. Treatment for lymphocytic leukemia typically involves chemotherapy, radiation, and/or stem cell transplant.

        Browse All Tags